Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0VP5X
|
||||
| Former ID |
DIB013871
|
||||
| Drug Name |
Research programme: peroxisome proliferator-activated receptor gamma agonist, Omeros
|
||||
| Synonyms |
PPAR gamma agonists (addiction); PPAR gamma agonists (addiction), Omeros; Peroxisome proliferated-activated receptor gamma agonists (addiction), Omeros
|
||||
| Indication | Drug abuse [ICD9: 303-304; ICD10:F10-F19] | Phase 2 | [549866] | ||
| Company |
Omeros Corp
|
||||
| Target and Pathway | |||||
| Target(s) | Peroxisome proliferator activated receptor gamma | Target Info | Agonist | [549867] | |
| PANTHER Pathway | CCKR signaling map ST | ||||
| WikiPathways | Wnt Signaling Pathway Netpath | ||||
| Nuclear Receptors in Lipid Metabolism and Toxicity | |||||
| Differentiation of white and brown adipocyte | |||||
| Regulation of Lipid Metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha) | |||||
| Transcriptional Regulation of White Adipocyte Differentiation | |||||
| Adipogenesis | |||||
| SREBP signalling | |||||
| Nuclear Receptors | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.